Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDY391 in Sjögren's Disease
NCT07737743Phase 2Recruiting
- Sponsor
- Novartis
- Start
- Aug 2026
- Primary completion
- Feb 2029
- Countries
- 6
01
Overview
A Phase 2 trial of DDY391 in Sjögren's syndrome, sponsored by Novartis. Started Aug 2026; status: recruiting.
02
Drugs
DDY391
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on NCT07737743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07737743.